TNGX vs DFTX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TNGX · Tango Therapeutics$21.73 ▼ 4.32%
DFTX · Definium Therapeutics$28.34 ▼ 3.87%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TNGX +110.4%
- DFTX +141.2%
Head to head
| Metric | TNGX | DFTX |
|---|---|---|
| Price | $21.73 | $28.34 |
| Change today | ▼ 4.32% | ▼ 3.87% |
| Market cap | $3.68B | $3.88B |
| Return, 3 months | -11.3% | -34.5% |
| Return, year to date | +145.3% | +111.7% |
| Return, 1 year | +116.7% | +165.4% |
| P/E (TTM) | – | – |
| P/B | 3.8 | 4.0 |
| P/E percentile vs own 5y | 14th | 9th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -100.0% | – |
| Net profit growth (YoY) | -530.6% | +24.2% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -36.5% | -61.4% |
| Analyst target vs. price | +124.0% | +162.2% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 44 | 34 |
| 30-day volatility | 95.4% | 69.1% |
| Max drawdown, 1 year | -36.6% | -41.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- DFTX is the largest of the group by market value.
- DFTX has returned the most over the past year.
- DFTX has been the calmest stock over the last 30 days.